Michael York
Plus aucun poste en cours
Fortune : 59 629 $ au 31/05/2023
Historique de carrière de Michael York
Anciens postes connus de Michael York
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| METACRINE, INC. | Comptroller/Controller/Auditor | 31/03/2022 | 24/03/2023 |
| Chief Executive Officer | 01/02/2023 | 24/03/2023 | |
| Director of Finance/CFO | 31/03/2022 | 24/03/2023 | |
| Corporate Officer/Principal | 01/12/2021 | 31/03/2022 | |
| President | 01/02/2023 | 24/03/2023 | |
| Corporate Secretary | 01/02/2023 | 24/03/2023 | |
| Treasurer | 31/03/2022 | 24/03/2023 | |
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2018 | 01/11/2021 |
| OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2015 | 01/06/2018 |
| Sente, Inc. | Chief Executive Officer | 01/07/2013 | 01/12/2014 |
| President | 01/07/2013 | 01/12/2014 | |
| SENTÉ Labs | Chief Executive Officer | - | - |
| President | - | - | |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formation de Michael York
| San Diego State University | Undergraduate Degree |
| University of Redlands | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 9 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| METACRINE, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
| Sente, Inc. | Technology Services |
| SENTÉ Labs |
- Bourse
- Insiders
- Michael York
- Expérience
